A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine

Cephalalgia

Volumn 35, Issue 10, 2015, Pages 931-937

  Neri, Monica ^a   Frustaci, Alessandra ^a   Milic, Mirta ^a,b   Valdiglesias, Vanessa ^a   Fini, Massimo ^a   Bonassi, Stefano ^a   Barbanti, Piero ^a  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

Biological markers; blood; case control studies; meta analysis; migraine; nitric oxide; oxidative stress; superoxide dismutase

Indexed keywords

BIOLOGICAL MARKER; GLUTATHIONE; HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; BLOOD LEVEL; CHROMATOGRAPHY; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NITROSATIVE STRESS; OXIDATIVE STRESS; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY; URINE LEVEL; BLOOD; CROSS-SECTIONAL STUDY; META ANALYSIS; METABOLISM; MIGRAINE DISORDERS; PHYSIOLOGY; URINE;

BIOMARKERS; CROSS-SECTIONAL STUDIES; HUMANS; MIGRAINE DISORDERS; NITRIC OXIDE; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84938770258     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102414564888     Document Type: Article

References (48)

1. Olesen J,. Nitric oxide-related drug targets in headache. Neurotherapeutics 2010; 7: 183-190.
2. Bernecker C, Ragginer C, Fauler G,. Oxidative stress is associated with migraine and migraine-related metabolic risk in females. Eur J Neurol 2011; 18: 1233-1239.
3. Bokhari FA, Shakoori TA, Hassan SA,. Plasma homocysteine in patients of migraine without aura. J Ayub Med Coll Abbottabad 2010; 22: 52-55.
4. Ciancarelli I, Tozzi-Ciancarelli MG, Spacca G,. Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia 2007; 27: 1136-1141.
5. Erol I, Alehan F, Aldemir D,. Increased vulnerability to oxidative stress in pediatric migraine patients. Pediatr Neurol 2010; 43: 21-24.
6. Choudhuri R, Cui L, Yong C,. Cortical spreading depression and gene regulation: Relevance to migraine. Ann Neurol 2002; 51: 499-506.
7. Dinia L, Bonzano L, Albano B,. White matter lesions progression in migraine with aura: A clinical and MRI longitudinal study. J Neuroimaging 2013; 23: 47-52.
8. Salat K, Moniczewski A, Librowski T,. Nitrogen, oxygen or sulfur containing heterocyclic compounds as analgesic drugs used as modulators of the nitroxidative stress. Mini Rev Med Chem 2013; 13: 335-352.
9. The International Classification of Headache Disorders, 3 rd edition (beta version). Cephalalgia 2013; 33: 629-808.
10. Frustaci A, Neri M, Cesario A,. Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses. Free Radic Biol Med 2012; 52: 2128-2141.
11. D'Amico D, Ferraris A, Leone M,. Increased plasma nitrites in migraine and cluster headache patients in interictal period: Basal hyperactivity of L-arginine-NO pathway? Cephalalgia 2002; 22: 33-36.
12. Hedman C, Winther K, Knudsen JB,. Platelet function in classic migraine during attack-free periods. Acta Neurol Scand 1988; 78: 271-277.
13. Silva FA, Rueda-Clausen CF, Silva SY,. Endothelial function in patients with migraine during the interictal period. Headache 2007; 47: 45-51.
14. Tietjen GE, Herial NA, White L,. Migraine and biomarkers of endothelial activation in young women. Stroke 2009; 40: 2977-2982.
15. Friedrich JO, Adhikari NK, Beyene J,. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods. J Clin Epidemiol 2011; 64: 556-564.
16. Deeks JJ, Altman DG, Bradburn MJ, Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG, (eds). Systematic reviews in health care: Meta-analysis in context, London: BMJ Books, 2005, pp. 2-312.
17. La Torre G,. Applied epidemiology and biostatistics, Torino: SE Ed, 2010.
18. StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP, 2011.
19. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988; 8 (Suppl 7): 1-96.
20. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 (Suppl 1): 9-160.
21. Bockowski L, Sobaniec W, Kulak W,. Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep 2008; 60: 542-548.
22. Shimomura T, Kowa H, Nakano T,. Platelet superoxide dismutase in migraine and tension-type headache. Cephalalgia 1994; 14: 215-218.
23. Shukla R, Barthwal MK, Srivastava N,. Neutrophil-free radical generation and enzymatic antioxidants in migraine patients. Cephalalgia 2004; 24: 37-43.
24. Tuncel D, Tolun FI, Gokce M,. Oxidative stress in migraine with and without aura. Biol Trace Elem Res 2008; 126: 92-97.
25. Ciancarelli I, Di Massimo C, Tozzi-Ciancarelli MG,. Helicobacter pylori infection and migraine. Cephalalgia 2002; 22: 222-225.
26. Tozzi-Ciancarelli MG, De Matteis G, Di Massimo C,. Oxidative stress and platelet responsiveness in migraine. Cephalalgia 1997; 17: 580-584.
27. Gavgani SC, Hoseinian MM,. Comparative study on homocysteine levels in migraine patients and normal peoples. Ann Biol Res 2012; 3: 1804-1807.
28. Bottini F, Celle ME, Calevo MG,. Metabolic and genetic risk factors for migraine in children. Cephalalgia 2006; 26: 731-737.
29. Moschiano F, D'Amico D, Usai S,. Homocysteine plasma levels in patients with migraine with aura. Neurol Sci 2008; 29 (Suppl 1): S173-S175.
30. Devasagayam TP, Boloor KK, Ramasarma T,. Methods for estimating lipid peroxidation: An analysis of merits and demerits. Indian J Biochem Biophys 2003; 40: 300-308.
31. Moselhy HF, Reid RG, Yousef S,. A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC. J Lipid Res 2013; 54: 852-858.
32. Gupta R, Kumar V, Luthra K,. Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects. J Headache Pain 2009; 10: 115-120.
33. Yilmaz G, Sürer H, Inan LE,. Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med 2007; 211: 23-30.
34. De Matteis G, Tozzi-Ciancarelli MG, Calisse P,. Platelet changes in classic migraine. Ital J Neurol Sci 1993; 14: 207-210.
35. Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C,. Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia 2003; 23: 39-42.
36. Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C,. Flunarizine effects on oxidative stress in migraine patients. Cephalalgia 2004; 24: 528-532.
37. Reed MC, Thomas RL, Pavisic J,. A mathematical model of glutathione metabolism. Theor Biol Med Model 2008; 5: 8-8.
38. Shukla R, Barthwal MK, Srivastava N,. Blood nitrite levels in patients with migraine during headache-free period. Headache 2001; 41: 475-481.
39. Gruber HJ, Bernecker C, Lechner A,. Increased nitric oxide stress is associated with migraine. Cephalalgia 2010; 30: 486-492.
40. Uzar E, Evliyaoglu O, Toprak G,. Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine. J Headache Pain 2011; 12: 239-243.
41. Sarchielli P, Alberti A, Codini M,. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 2000; 20: 907-918.
42. Fidan I, Yuksel S, Ymir T,. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 2006; 171: 184-188.
43. Guldiken B, Demir M, Guldiken S,. Asymmetric dimethylarginine and nitric oxide levels in migraine during the interictal period. J Clin Neurosci 2009; 16: 672-674.
44. Shimomura T, Murakami F, Kotani K,. Platelet nitric oxide metabolites in migraine. Cephalalgia 1999; 19: 218-222.
45. Gallai V, Floridi A, Mazzotta G,. L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura. Acta Neurol Scand 1996; 94: 151-160.
46. Gruber HJ, Bernecker C, Pailer S,. Increased dopamine is associated with the cGMP and homocysteine pathway in female migraineurs. Headache 2010; 50: 109-116.
47. Ioannidis JP, Trikalinos TA,. The appropriateness of asymmetry tests for publication bias in meta-analyses: A large survey. CMAJ 2007; 176: 1091-1096.
48. Hering-Hanit R, Gadoth N, Yavetz A,. Is blood homocysteine elevated in migraine? Headache 2001; 41: 779-781.